Whole-genome sequencing in autism identifies hot spots for de novo germline mutation

Cell. 2012 Dec 21;151(7):1431-42. doi: 10.1016/j.cell.2012.11.019.

Abstract

De novo mutation plays an important role in autism spectrum disorders (ASDs). Notably, pathogenic copy number variants (CNVs) are characterized by high mutation rates. We hypothesize that hypermutability is a property of ASD genes and may also include nucleotide-substitution hot spots. We investigated global patterns of germline mutation by whole-genome sequencing of monozygotic twins concordant for ASD and their parents. Mutation rates varied widely throughout the genome (by 100-fold) and could be explained by intrinsic characteristics of DNA sequence and chromatin structure. Dense clusters of mutations within individual genomes were attributable to compound mutation or gene conversion. Hypermutability was a characteristic of genes involved in ASD and other diseases. In addition, genes impacted by mutations in this study were associated with ASD in independent exome-sequencing data sets. Our findings suggest that regional hypermutation is a significant factor shaping patterns of genetic variation and disease risk in humans.

Publication types

  • Research Support, N.I.H., Extramural
  • Twin Study

MeSH terms

  • Animals
  • Autistic Disorder / genetics*
  • Cell Line
  • Exons
  • Female
  • Genome-Wide Association Study*
  • Germ-Line Mutation*
  • Humans
  • Male
  • Maternal Age
  • Mutation Rate*
  • Pan troglodytes / genetics
  • Paternal Age
  • Sequence Analysis, DNA
  • Twins, Monozygotic